The Effect of Chelation on Bone Pb Stores in Pb Poisoned Children
-
2024/12/03
-
Details
-
Personal Author:
-
Description:Background: Lead exposure remains a key problem for children during development. One treatment for lead poisoning is chelation - a topic that remains controversial with varied results. Bone lead serves as a marker of total body burden of lead and encompasses between 60-90% of lead storage in children. Objective: In this study, we aimed to identify the change in bone lead as a result of chelation therapy in a group of lead poisoned children (blood lead >25 µg/dL). Methods: Upon diagnosis with lead poisoning at Xinhua Hospital in Shanghai, China, children were recruited to our study, had their bone lead levels measured, and underwent one-week of intravenous, in-patient ethylenediaminetetraacetic acid chelation treatment. Up to three clinical visits with the same treatment protocol and bone lead measurements were completed over the two-year study. We measured biomarkers of lead exposure for children exposed via various potential sources, including home contaminants, local industrial emissions, traditional medicines, or lead cookware. Results: We observed significant differences with bone lead after chelation therapy (p < 0.0001), even after calculating a conservative model for theoretical decay from known bone turnover (p = 0.01). The difference identified between our observed change in bone lead and literature established bone lead change significantly increased with more chelation treatments. A significant reduction in bone lead was observed following chelation treatment of children with lead poisoning - a difference that increased more with more chelation. Significance: Study results indicate that chelation treatment is effective in reducing bone lead stores in children with initial blood lead levels greater than 25 µg/dL. Impact Statement: Lead exposure in children is a consistent problem - drastically impacting health across the life span. After exposure, lead stores in the bone of children serving as a potential endogenous source of exposure for years to decades. Our study demonstrated that chelation therapy, while reducing blood lead levels, additionally reduced bone lead levels. A reduction in bone lead would effectively reduce the potential for endogenous release of lead and restrict the damage done by lead exposure. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1559-0631
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
NIOSHTIC Number:nn:20070541
-
Citation:J Expo Sci Environ Epidemiol 2024 Dec; :[Epub ahead of print]
-
Contact Point Address:Aaron J. Specht, School of Health Sciences, Purdue University, West Lafayette, IN, USA
-
Email:aspecht@purdue.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2025
-
Performing Organization:Purdue University
-
Peer Reviewed:True
-
Start Date:20210901
-
Source Full Name:Journal of Exposure Science and Environmental Epidemiology
-
End Date:20220731
-
Collection(s):
-
Main Document Checksum:urn:sha-512:88e06119df82eb701d47979405c8a16726182dc754a6a85703c8f3d8c3eec834f352e70dce7ebf25a75b6f7e323793cae8b3259496a7c07a2ce30bf6d99b585e
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like